Dr. Anna Kulesza joins Nuclidium
NUCLIDIUM to Present Data from Three Clinical-Ready Precision Oncology Programs at the 36th Annual EANM Congress
NUCLIDIUM to Present Data from Three Clinical-Ready Precision Oncology Programs at the 36th Annual EANM Congress
NUCLIDIUM to Present Data from Three Clinical-Ready Precision Oncology Programs at the 36th Annual EANM Congress
Our CEO Leila Jaafar will present the company and our unique copper-based approach at the upcoming conferences. Meet us there!